chr16-89918196-T-C

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The ENST00000570217.1(ENSG00000267048):​n.522T>C variant causes a non coding transcript exon change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.574 in 229,264 control chromosomes in the GnomAD database, including 42,573 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.60 ( 30294 hom., cov: 33)
Exomes 𝑓: 0.53 ( 12279 hom. )

Consequence

ENSG00000267048
ENST00000570217.1 non_coding_transcript_exon

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:3

Conservation

PhyloP100: -2.36

Publications

9 publications found
Variant links:
Genes affected
MC1R (HGNC:6929): (melanocortin 1 receptor) This intronless gene encodes the receptor protein for melanocyte-stimulating hormone (MSH). The encoded protein, a seven pass transmembrane G protein coupled receptor, controls melanogenesis. Two types of melanin exist: red pheomelanin and black eumelanin. Gene mutations that lead to a loss in function are associated with increased pheomelanin production, which leads to lighter skin and hair color. Eumelanin is photoprotective but pheomelanin may contribute to UV-induced skin damage by generating free radicals upon UV radiation. Binding of MSH to its receptor activates the receptor and stimulates eumelanin synthesis. This receptor is a major determining factor in sun sensitivity and is a genetic risk factor for melanoma and non-melanoma skin cancer. Over 30 variant alleles have been identified which correlate with skin and hair color, providing evidence that this gene is an important component in determining normal human pigment variation. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.88).
BP6
Variant 16-89918196-T-C is Benign according to our data. Variant chr16-89918196-T-C is described in ClinVar as [Benign]. Clinvar id is 321389.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.896 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
LOC124903759XM_047435031.1 linkc.1212+149T>C intron_variant Intron 3 of 3 XP_047290987.1
LOC124903759XM_047435032.1 linkc.*351T>C downstream_gene_variant XP_047290988.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
ENSG00000267048ENST00000570217.1 linkn.522T>C non_coding_transcript_exon_variant Exon 3 of 3 4
MC1RENST00000555427.1 linkc.-409+149T>C intron_variant Intron 2 of 3 5 ENSP00000451760.1 G3V4F0
MC1RENST00000639847.1 linkc.-409+149T>C intron_variant Intron 2 of 2 5 ENSP00000492011.1 Q01726

Frequencies

GnomAD3 genomes
AF:
0.597
AC:
90748
AN:
151954
Hom.:
30231
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.875
Gnomad AMI
AF:
0.359
Gnomad AMR
AF:
0.587
Gnomad ASJ
AF:
0.407
Gnomad EAS
AF:
0.917
Gnomad SAS
AF:
0.679
Gnomad FIN
AF:
0.518
Gnomad MID
AF:
0.589
Gnomad NFE
AF:
0.426
Gnomad OTH
AF:
0.551
GnomAD4 exome
AF:
0.528
AC:
40796
AN:
77192
Hom.:
12279
Cov.:
0
AF XY:
0.523
AC XY:
18632
AN XY:
35636
show subpopulations
African (AFR)
AF:
0.877
AC:
3191
AN:
3640
American (AMR)
AF:
0.622
AC:
1487
AN:
2390
Ashkenazi Jewish (ASJ)
AF:
0.407
AC:
1978
AN:
4854
East Asian (EAS)
AF:
0.915
AC:
10103
AN:
11042
South Asian (SAS)
AF:
0.655
AC:
431
AN:
658
European-Finnish (FIN)
AF:
0.569
AC:
33
AN:
58
Middle Eastern (MID)
AF:
0.532
AC:
249
AN:
468
European-Non Finnish (NFE)
AF:
0.420
AC:
20019
AN:
47654
Other (OTH)
AF:
0.514
AC:
3305
AN:
6428
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.496
Heterozygous variant carriers
0
809
1618
2426
3235
4044
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
124
248
372
496
620
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.598
AC:
90872
AN:
152072
Hom.:
30294
Cov.:
33
AF XY:
0.602
AC XY:
44778
AN XY:
74338
show subpopulations
African (AFR)
AF:
0.876
AC:
36373
AN:
41538
American (AMR)
AF:
0.588
AC:
8992
AN:
15298
Ashkenazi Jewish (ASJ)
AF:
0.407
AC:
1411
AN:
3464
East Asian (EAS)
AF:
0.918
AC:
4731
AN:
5156
South Asian (SAS)
AF:
0.678
AC:
3270
AN:
4826
European-Finnish (FIN)
AF:
0.518
AC:
5476
AN:
10566
Middle Eastern (MID)
AF:
0.595
AC:
175
AN:
294
European-Non Finnish (NFE)
AF:
0.426
AC:
28948
AN:
67910
Other (OTH)
AF:
0.554
AC:
1171
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.506
Heterozygous variant carriers
0
1635
3270
4904
6539
8174
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
726
1452
2178
2904
3630
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.438
Hom.:
2966
Bravo
AF:
0.615
Asia WGS
AF:
0.777
AC:
2704
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
Jan 10, 2019
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Melanoma, cutaneous malignant, susceptibility to, 5 Benign:1
Jan 12, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.88
CADD
Benign
4.9
DANN
Benign
0.64
PhyloP100
-2.4
Mutation Taster
=300/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.050
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs3212357; hg19: chr16-89984604; API